Cytek Biosciences Inc (CTKB) stock price

Cytek Biosciences Inc (CTKB) is a Healthcare · Medical Devices company listed on NASDAQ. Price $5.22 (+0.19%), Market cap $0.46B, 52-week low–high $2.42 ~ $5.88.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kit

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Cytek Biosciences Inc are updated in real time on BlackAll Trade.

Cytek Biosciences Inc financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Cytek Biosciences Inc (CTKB) stock price?

Cytek Biosciences Inc trades at $5.22 (+0.19%). Real-time quotes and charts are available on BlackAll Trade.

What is the Cytek Biosciences Inc (CTKB) market cap?

Cytek Biosciences Inc has a market cap of about $0.46B.

What does Cytek Biosciences Inc (CTKB) do?

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek